Diabetologia 63 (11), 24342445 (2020)
Evaluate the marketing claims Does the marketing claim equivalence with prescription medications
Unlike Semaglutide weight loss treatments (such as Ozempic and Wegovy), which activate only the GLP-1 receptor, Tirzepatide is a dual-action therapy that targets both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
We just care more than one of those faceless corporate brands
It identifies nutrients that cannot be manufactured in the body and must be consumed in ones diet
Importantly, in all previous studies, hormonal effects on binge eating and emotional eating were independent of covariates that could also change across the menstrual cycle, such as negative affect and body mass index (BMI) (54, 55, 59, 60)